Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 3 de 3
1.
Am J Ophthalmol ; 208: 376-386, 2019 12.
Article En | MEDLINE | ID: mdl-31449790

PURPOSE: To evaluate outcomes of patients treated with intensive intravitreal therapy and to describe the evolution of quantitative real-time polymerase chain reaction (qPCR) in patients treated for acute retinal necrosis (ARN) syndrome. DESIGN: Retrospective observational case series. METHODS: This study included 25 eyes of 24 patients with ARN who were treated and followed up in 2 departments of ophthalmology in Lyon, France. Assessed outcomes included qPCR viral load profile during treatment, number of antiviral intravitreal injections (IVT), retinal detachment rate, and best-corrected visual acuity. RESULTS: Final visual acuity was 20/200 or less in 20% of cases; the rate of retinal detachment was 16%. Viral load kinetics changed in 3 phases: a first plateau period that was not consistent, a logarithmic decrease phase, and a negativation phase. Mean decay of the logarithm of the viral load was estimated at 0.076 per day; mean time of negativation was 56.1 days. Median IVT number was 9 (range, 0-28). Ten patients were treated with injections until the viral load was undetectable. Resistance to acyclovir was observed in a patient with a prolonged initial plateau of the viral load. CONCLUSIONS: Numerous and prolonged IVTs, used as adjunctive therapy, could improve the prognosis of treated patients by decreasing the risk of retinal detachment and improving visual acuity. QPCR enables monitoring of the response to treatment and can provide evidence for resistance to antiviral treatment by enabling the detection of cases with a prolonged initial plateau of viral load.


Antiviral Agents/therapeutic use , Cytomegalovirus Retinitis/virology , Eye Infections, Viral/virology , Herpes Simplex/virology , Herpes Zoster Ophthalmicus/virology , Retinal Necrosis Syndrome, Acute/virology , Adult , Aged , Aged, 80 and over , Aqueous Humor/virology , Cytomegalovirus Retinitis/drug therapy , DNA, Viral/genetics , Eye Infections, Viral/drug therapy , Female , Foscarnet/therapeutic use , Ganciclovir/therapeutic use , Herpes Simplex/drug therapy , Herpes Zoster Ophthalmicus/drug therapy , Herpesvirus 1, Human/genetics , Herpesvirus 1, Human/isolation & purification , Herpesvirus 2, Human/genetics , Herpesvirus 2, Human/isolation & purification , Herpesvirus 3, Human/genetics , Herpesvirus 3, Human/isolation & purification , Humans , Intravitreal Injections , Male , Middle Aged , Real-Time Polymerase Chain Reaction , Retinal Necrosis Syndrome, Acute/drug therapy , Retrospective Studies , Viral Load/physiology , Visual Acuity/physiology , Young Adult
3.
Cell Transplant ; 27(2): 264-274, 2018 02.
Article En | MEDLINE | ID: mdl-29637812

Total bilateral limbal stem cell deficiency leading to loss of corneal clarity, potential vision loss, pain, photophobia, and keratoplasty failure cannot be treated by autologous limbal transplantation, and allogeneic limbal transplantation requires subsequent immunosuppressive treatment. Cultured autologous oral mucosal epithelial cells have been shown to be safe and effective alternatives. These cells can be transplanted on supports or without support after detachment from the culture dishes. Dispase, known for epidermal sheet detachment, is reported as not usable for oral mucosa. The objective was to find an optimized detachment method providing a sufficiently resistant and adhesive cultured oral mucosal epithelium (COME), which can be grafted without sutures. Enzymatic treatments (dispase or collagenase at different concentrations) were compared to enzyme-free mechanical detachment. Histological immunofluorescence (IF) and Western blotting (WB) were used to examine the impact on adhesion markers (laminin-332, ß1-integrin, and type VII collagen) and junctional markers (E-cadherin, P-cadherin). Finally, the COME ability to adhere to the cornea and produce a differentiated epithelium 15 d after grafting onto an ex vivo porcine stroma model were investigated by histology, IF, and transmission electron microscopy. Collagenase at 0.5 mg/mL and dispase at 5 mg/mL were selected for comparative study on adhesive expression marker by IF and WB showed that levels of basement membrane proteins and cell-cell and cell-matrix junction proteins were not significantly different between the 3 detachment methods. Collagenase 0.5 mg/mL was selected for the next step validation because of the better reproducibility, 100% success (vs. 33% with dispase 5 mg/mL). Grafted onto porcine de-epithelialized corneal stroma, collagenase 0.5 mg/mL detached COME were found to adhere, stratify, and continue to ensure renewal of the epithelium. For COME, collagenase 0.5 mg/mL enzymatic detachment was selected and validated on its resistance and adhesive marker expression as well as their anchorage onto our new ex vivo de-epithelialized stroma model.


Basement Membrane/cytology , Limbus Corneae/pathology , Mouth Mucosa/cytology , Stem Cells/cytology , Animals , Basement Membrane/ultrastructure , Cells, Cultured , Corneal Diseases/therapy , Humans , Microscopy, Electron, Transmission , Mouth Mucosa/ultrastructure , Stem Cell Transplantation/methods , Stem Cells/ultrastructure , Swine
...